Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS).


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 7 11 2020
medline: 21 7 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

Cognitive impairment is now recognized in a subset of patients with amyotrophic lateral sclerosis (ALS). The objective of the study was to identify group differences and neuroanatomical correlates of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in participants ALS. Fifty-three ALS patients and 43 healthy controls recruited as a part of our multicentre study (CALSNIC) were administered the ECAS and underwent an MRI scan. Voxel-based morphometry and tract based spatial statistics (TBSS) was performed to identify structural changes and associations with impaired ECAS scores. Lower performance in the ECAS verbal fluency and executive domains were noted in ALS patients as compared to controls (p < 0.01). Extensive white matter degeneration was noted in the corticospinal tract in all ALS patients, while ALS patients with impaired verbal fluency or executive domains (ALS-exi, n = 22), displayed additional degeneration in the corpus callosum, cingulum and superior longitudinal fasciculus as compared to controls (p < 0.05, TFCE corrected). Mild grey matter changes and associations with ECAS verbal fluency or executive performance were noted at lenient statistical thresholds (p < 0.001, uncorrected). Executive impairment was detected using the ECAS in our multicentre sample of Canadian ALS patients. White matter degeneration in motor regions was revealed in ALS patients with extensive spread to frontal regions in the ALS-exi sub-group. Mild associations between ECAS verbal fluency, executive function scores and MRI metrics suggest that reduced performance may be associated with widespread structural integrity.

Identifiants

pubmed: 33155172
doi: 10.1007/s11682-020-00359-7
pii: 10.1007/s11682-020-00359-7
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1641-1654

Subventions

Organisme : CIHR
ID : CIHR MOP 123534
Pays : Canada
Organisme : CIHR
ID : CIHR MOP 123534
Pays : Canada

Informations de copyright

© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Abdulla, S., Machts, J., Kaufmann, J., Patrick, K., Kollewe, K., Dengler, R., Heinze, H. J., Petri, S., Vielhaber, S., & Nestor, P. J. (2014). Hippocampal degeneration in patients with amyotrophic lateral sclerosis. Neurobiology of Aging, 35(11), 2639–2645. https://doi.org/10.1016/j.neurobiolaging.2014.05.035 .
doi: 10.1016/j.neurobiolaging.2014.05.035 pubmed: 25004891
Abe, K., Fujimura, H., Toyooka, K., Sakoda, S., Yorifuji, S., & Yanagihara, T. (1997). Cognitive function in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 148(1), 95–100.
doi: 10.1016/S0022-510X(96)05338-5
Abrahams, S., Goldstein, L. H., Al-Chalabi, A., Pickering, A., Morris, R. G., Passingham, R. E., et al. (1997). Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. Journal of Neurol Neurosurg Psychiatry, 62(5), 464–472.
doi: 10.1136/jnnp.62.5.464
Abrahams, S., Leigh, P. N., Harvey, A., Vythelingum, G. N., Grise, D., & Goldstein, L. H. (2000). Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia, 38(6), 734–747.
doi: 10.1016/S0028-3932(99)00146-3
Abrahams, S., Newton, J., Niven, E., Foley, J., & Bak, T. H. (2014). Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 15(1–2), 9–14. https://doi.org/10.3109/21678421.2013.805784 .
doi: 10.3109/21678421.2013.805784 pubmed: 23781974
Agosta, F., Rocca, M. A., Valsasina, P., Sala, S., Caputo, D., Perini, M., Salvi, F., Prelle, A., & Filippi, M. (2009). A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. Journal of Neurology, Neurosurgery, and Psychiatry, 80(1), 53–55. https://doi.org/10.1136/jnnp.2008.154252 .
doi: 10.1136/jnnp.2008.154252 pubmed: 18931009
Agosta, F., Pagani, E., Petrolini, M., Caputo, D., Perini, M., Prelle, A., Salvi, F., & Filippi, M. (2010). Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: A diffusion tensor MR imaging tractography study. AJNR. American Journal of Neuroradiology, 31(8), 1457–1461. https://doi.org/10.3174/ajnr.A2105 .
doi: 10.3174/ajnr.A2105 pubmed: 20395382 pmcid: 7966122
Agosta, F., Ferraro, P. M., Riva, N., Spinelli, E. G., Chio, A., Canu, E., et al. (2016). Structural brain correlates of cognitive and behavioral impairment in MND. Human Brain Mapping, 37(4), 1614–1626. https://doi.org/10.1002/hbm.23124 .
doi: 10.1002/hbm.23124 pubmed: 26833930 pmcid: 6867462
Bach, M., Laun, F. B., Leemans, A., Tax, C. M., Biessels, G. J., Stieltjes, B., et al. (2014). Methodological considerations on tract-based spatial statistics (TBSS). Neuroimage, 100, 358–369. https://doi.org/10.1016/j.neuroimage.2014.06.021 .
doi: 10.1016/j.neuroimage.2014.06.021 pubmed: 24945661
Beaulieu, C. (2002). The basis of anisotropic water diffusion in the nervous system - a technical review. NMR in Biomedicine, 15(7–8), 435–455. https://doi.org/10.1002/nbm.782 .
doi: 10.1002/nbm.782 pubmed: 12489094
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck depression inventory-II. San Antonio: Psychological Corporation.
Bede, P., Bokde, A., Elamin, M., Byrne, S., McLaughlin, R. L., Jordan, N., Hampel, H., Gallagher, L., Lynch, C., Fagan, A. J., Pender, N., & Hardiman, O. (2013). Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): A neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. Journal of Neurology, Neurosurgery, and Psychiatry, 84(7), 766–773. https://doi.org/10.1136/jnnp-2012-302674 .
doi: 10.1136/jnnp-2012-302674 pubmed: 23085933
Birn, R. M., Kenworthy, L., Case, L., Caravella, R., Jones, T. B., Bandettini, P. A., & Martin, A. (2010). Neural systems supporting lexical search guided by letter and semantic category cues: A self-paced overt response fMRI study of verbal fluency. Neuroimage, 49(1), 1099–1107. https://doi.org/10.1016/j.neuroimage.2009.07.036 .
doi: 10.1016/j.neuroimage.2009.07.036 pubmed: 19632335
Braak, H., Brettschneider, J., Ludolph, A. C., Lee, V. M., Trojanowski, J. Q., & Del Tredici, K. (2013). Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nature Reviews. Neurology, 9(12), 708–714. https://doi.org/10.1038/nrneurol.2013.221 .
doi: 10.1038/nrneurol.2013.221 pubmed: 24217521 pmcid: 3943211
Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., et al. (2013). Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Annals of Neurology, 74(1), 20–38. https://doi.org/10.1002/ana.23937 .
doi: 10.1002/ana.23937 pubmed: 23686809 pmcid: 3785076
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(5), 293–299.
doi: 10.1080/146608200300079536
Burke, T., Lonergan, K., Pinto-Grau, M., Elamin, M., Bede, P., Madden, C., Hardiman, O., & Pender, N. (2017). Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: Executive function as a mediator, and predictor of performance. Amyotroph Lateral Scler Frontotemporal Degener, 18(3–4), 193–201. https://doi.org/10.1080/21678421.2016.1272615 .
doi: 10.1080/21678421.2016.1272615 pubmed: 28084080
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III). Journal of the Neurological Sciences, 169(1–2), 13–21.
doi: 10.1016/S0022-510X(99)00210-5
Chang, J. L., Lomen-Hoerth, C., Murphy, J., Henry, R. G., Kramer, J. H., Miller, B. L., & Gorno-Tempini, M. L. (2005). A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology, 65(1), 75–80. https://doi.org/10.1212/01.wnl.0000167602.38643.29 .
doi: 10.1212/01.wnl.0000167602.38643.29 pubmed: 16009889
Christidi, F., Karavasilis, E., Riederer, F., Zalonis, I., Ferentinos, P., Velonakis, G., Xirou, S., Rentzos, M., Argiropoulos, G., Zouvelou, V., Zambelis, T., Athanasakos, A., Toulas, P., Vadikolias, K., Efstathopoulos, E., Kollias, S., Karandreas, N., Kelekis, N., & Evdokimidis, I. (2018). Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. Brain Imaging and Behavior, 12(2), 547–563. https://doi.org/10.1007/s11682-017-9722-y .
doi: 10.1007/s11682-017-9722-y pubmed: 28425061
Dimond, D., Ishaque, A., Chenji, S., Mah, D., Chen, Z., Seres, P., Beaulieu, C., & Kalra, S. (2017). White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis. Human Brain Mapping, 38(3), 1249–1268. https://doi.org/10.1002/hbm.23452 .
doi: 10.1002/hbm.23452 pubmed: 27796080
Goldstein, L. H., & Abrahams, S. (2013). Changes in cognition and behaviour in amyotrophic lateral sclerosis: Nature of impairment and implications for assessment. Lancet Neurology, 12(4), 368–380. https://doi.org/10.1016/S1474-4422(13)70026-7 .
doi: 10.1016/S1474-4422(13)70026-7 pubmed: 23518330
Kasper, E., Schuster, C., Machts, J., Kaufmann, J., Bittner, D., Vielhaber, S., Benecke, R., Teipel, S., & Prudlo, J. (2014). Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using DTI. PLoS One, 9(12), e114543. https://doi.org/10.1371/journal.pone.0114543 .
doi: 10.1371/journal.pone.0114543 pubmed: 25501028 pmcid: 4263750
Kaufmann, P., Pullman, S. L., Shungu, D. C., Chan, S., Hays, A. P., Del Bene, M. L., et al. (2004). Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology, 62(10), 1753–1757.
doi: 10.1212/01.WNL.0000125182.17874.59
Keller, J., Bohm, S., Aho-Ozhan, H. E. A., Loose, M., Gorges, M., Kassubek, J., et al. (2017). Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis. Brain Imaging and Behavior, 12, 771–784. https://doi.org/10.1007/s11682-017-9738-3 .
doi: 10.1007/s11682-017-9738-3
Kew, J. J., Goldstein, L. H., Leigh, P. N., Abrahams, S., Cosgrave, N., Passingham, R. E., et al. (1993). The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain, 116(Pt 6), 1399–1423.
doi: 10.1093/brain/116.6.1399
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011). Amyotrophic lateral sclerosis. Lancet, 377(9769), 942–955. https://doi.org/10.1016/S0140-6736(10)61156-7 .
doi: 10.1016/S0140-6736(10)61156-7 pubmed: 21296405
Kimura, F., Fujimura, C., Ishida, S., Nakajima, H., Furutama, D., Uehara, H., Shinoda, K., Sugino, M., & Hanafusa, T. (2006). Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology, 66(2), 265–267. https://doi.org/10.1212/01.wnl.0000194316.91908.8a .
doi: 10.1212/01.wnl.0000194316.91908.8a pubmed: 16434671
Leemans, A, Jeurissen, B, Sijbers, J, and Jones, DK (2009). ExploreDTI: A graphical toolbox for processing, analyzing, and visualizing diffusion MR data. Paper presented at the 17th annual meeting of Intl Soc mag Reson med, Hawaii, USA,
Loose, M, Burkhardt, C, Aho-Ozhan, H, Keller, J, Abdulla, S, Bohm, S, et al. (2016). Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener, 1-3, doi: https://doi.org/10.3109/21678421.2016.1162814 .
Lulé, D., Burkhardt, C., Abdulla, S., Bohm, S., Kollewe, K., Uttner, I., et al. (2015). The Edinburgh cognitive and Behavioural amyotrophic lateral sclerosis screen: A cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener, 16(1–2), 16–23. https://doi.org/10.3109/21678421.2014.959451 .
doi: 10.3109/21678421.2014.959451 pubmed: 25292386
Lulé, D., Bohm, S., Muller, H. P., Aho-Ozhan, H., Keller, J., Gorges, M., et al. (2018). Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex, 101, 163–171. https://doi.org/10.1016/j.cortex.2018.01.004 .
doi: 10.1016/j.cortex.2018.01.004 pubmed: 29477906
Machts, J., Bittner, V., Kasper, E., Schuster, C., Prudlo, J., Abdulla, S., Kollewe, K., Petri, S., Dengler, R., Heinze, H. J., Vielhaber, S., Schoenfeld, M. A., & Bittner, D. M. (2014). Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: A comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neuroscience, 15, 83.
doi: 10.1186/1471-2202-15-83
Maldjian, J. A., Laurienti, P. J., Kraft, R. A., & Burdette, J. H. (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage, 19(3), 1233–1239.
doi: 10.1016/S1053-8119(03)00169-1
Menke, R. A., Korner, S., Filippini, N., Douaud, G., Knight, S., Talbot, K., et al. (2014). Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain, 137(Pt 9), 2546–2555.
doi: 10.1093/brain/awu162
Menke, R. A., Proudfoot, M., Wuu, J., Andersen, P. M., Talbot, K., Benatar, M., et al. (2016). Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk. Journal of Neurology, Neurosurgery, and Psychiatry, 87(6), 580–588. https://doi.org/10.1136/jnnp-2015-311945 .
doi: 10.1136/jnnp-2015-311945 pubmed: 26733601
Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006). The Addenbrooke's cognitive examination revised (ACE-R): A brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry, 21(11), 1078–1085. https://doi.org/10.1002/gps.1610 .
doi: 10.1002/gps.1610 pubmed: 16977673
Mioshi, E., Lillo, P., Yew, B., Hsieh, S., Savage, S., Hodges, J. R., Kiernan, M. C., & Hornberger, M. (2013). Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology, 80(12), 1117–1123.
doi: 10.1212/WNL.0b013e31828869da
Mitsumoto, H., Ulug, A. M., Pullman, S. L., Gooch, C. L., Chan, S., Tang, M. X., et al. (2007). Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology, 68(17), 1402–1410. https://doi.org/10.1212/01.wnl.0000260065.57832.87 .
doi: 10.1212/01.wnl.0000260065.57832.87 pubmed: 17452585
Müller, H. P., Turner, M. R., Grosskreutz, J., Abrahams, S., Bede, P., Govind, V., Prudlo, J., Ludolph, A. C., Filippi, M., & Kassubek, J. (2016). A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 87(6), 570–579. https://doi.org/10.1136/jnnp-2015-311952 .
doi: 10.1136/jnnp-2015-311952 pubmed: 26746186
Niven, E., Newton, J., Foley, J., Colville, S., Swingler, R., Chandran, S., Bak, T. H., & Abrahams, S. (2015). Validation of the Edinburgh cognitive and Behavioural amyotrophic lateral sclerosis screen (ECAS): A cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener, 16(3–4), 172–179. https://doi.org/10.3109/21678421.2015.1030430 .
doi: 10.3109/21678421.2015.1030430 pubmed: 25967542
Phukan, J., Elamin, M., Bede, P., Jordan, N., Gallagher, L., Byrne, S., Lynch, C., Pender, N., & Hardiman, O. (2012). The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. Journal of Neurology & Psychiatry, 83(1), 102–108.
doi: 10.1136/jnnp-2011-300188
Pinto-Grau, M., Burke, T., Lonergan, K., McHugh, C., Mays, I., Madden, C., Vajda, A., Heverin, M., Elamin, M., Hardiman, O., & Pender, N. (2017). Screening for cognitive dysfunction in ALS: Validation of the Edinburgh cognitive and Behavioural ALS screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Frontotemporal Degener, 18(1–2), 99–106. https://doi.org/10.1080/21678421.2016.1249887 .
doi: 10.1080/21678421.2016.1249887 pubmed: 27894201
Poletti, B., Solca, F., Carelli, L., Madotto, F., Lafronza, A., Faini, A., Monti, A., Zago, S., Calini, D., Tiloca, C., Doretti, A., Verde, F., Ratti, A., Ticozzi, N., Abrahams, S., & Silani, V. (2016). The validation of the Italian Edinburgh cognitive and Behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener, 17(7–8), 489–498. https://doi.org/10.1080/21678421.2016.1183679 .
doi: 10.1080/21678421.2016.1183679 pubmed: 27219526
Sarro, L., Agosta, F., Canu, E., Riva, N., Prelle, A., Copetti, M., Riccitelli, G., Comi, G., & Filippi, M. (2011). Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: A diffusion tensor tractography study. Ajnr: American Journal of Neuroradiology, 32(10), 1866–1872.
doi: 10.3174/ajnr.A2658
Schuster, C., Kasper, E., Dyrba, M., Machts, J., Bittner, D., Kaufmann, J., Mitchell, A. J., Benecke, R., Teipel, S., Vielhaber, S., & Prudlo, J. (2014). Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiology of Aging, 35(1), 240–246. https://doi.org/10.1016/j.neurobiolaging.2013.07.020 .
doi: 10.1016/j.neurobiolaging.2013.07.020 pubmed: 23992619
Senda, J., Ito, M., Watanabe, H., Atsuta, N., Kawai, Y., Katsuno, M., Tanaka, F., Naganawa, S., Fukatsu, H., & Sobue, G. (2009). Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: A study with tractography and diffusion-tensor imaging. Amyotrophic Lateral Sclerosis, 10(5–6), 288–294. https://doi.org/10.3109/17482960802651717 .
doi: 10.3109/17482960802651717 pubmed: 19922115
Sgobio, C., Trabalza, A., Spalloni, A., Zona, C., Carunchio, I., Longone, P., & Ammassari-Teule, M. (2008). Abnormal medial prefrontal cortex connectivity and defective fear extinction in the presymptomatic G93A SOD1 mouse model of ALS. Genes, Brain, & Behavior, 7(4), 427–434.
doi: 10.1111/j.1601-183X.2007.00367.x
Siciliano, M., Trojano, L., Trojsi, F., Greco, R., Santoro, M., Basile, G., Piscopo, F., D’Iorio, A., Patrone, M., Femiano, C., Monsurrò, M., Tedeschi, G., & Santangelo, G. (2017). Edinburgh cognitive and Behavioural ALS screen (ECAS)-Italian version: Regression based norms and equivalent scores. Neurological Sciences, 38(6), 1059–1068. https://doi.org/10.1007/s10072-017-2919-4 .
doi: 10.1007/s10072-017-2919-4 pubmed: 28332040
Song, S. K., Sun, S. W., Ju, W. K., Lin, S. J., Cross, A. H., & Neufeld, A. H. (2003). Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage, 20(3), 1714–1722.
doi: 10.1016/j.neuroimage.2003.07.005
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., McLaughlin, P., Snowden, J., et al. (2017). Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener, 18(3–4), 153–174. https://doi.org/10.1080/21678421.2016.1267768 .
doi: 10.1080/21678421.2016.1267768 pubmed: 28054827 pmcid: 7409990
Taylor, L. J., Brown, R. G., Tsermentseli, S., AlChalabi, A., Shaw, C. E., Ellis, C. M., et al. (2013). Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? Journal of Neurology & Psychiatry, 84(5), 494–498.
doi: 10.1136/jnnp-2012-303526
Trojsi, F., Caiazzo, G., Siciliano, M., Femiano, C., Passaniti, C., Russo, A., Bisecco, A., Monsurrò, M. R., Cirillo, M., Esposito, F., Tedeschi, G., & Santangelo, G. (2019). Microstructural correlates of Edinburgh cognitive and Behavioural ALS screen (ECAS) changes in amyotrophic lateral sclerosis. Psychiatry Research: Neuroimaging, 288, 67–75. https://doi.org/10.1016/j.pscychresns.2019.04.001 .
doi: 10.1016/j.pscychresns.2019.04.001 pubmed: 30987770
Turner, M. R., Grosskreutz, J., Kassubek, J., Abrahams, S., Agosta, F., Benatar, M., Filippi, M., Goldstein, L. H., van den Heuvel, M., Kalra, S., Lulé, D., Mohammadi, B., & first Neuroimaging Symosium in ALS (NISALS). (2011). Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurology, 10(5), 400–403. https://doi.org/10.1016/S1474-4422(11)70049-7 .
doi: 10.1016/S1474-4422(11)70049-7 pubmed: 21511189
Witgert, M., Salamone, A. R., Strutt, A. M., Jawaid, A., Massman, P. J., Bradshaw, M., Mosnik, D., Appel, S. H., & Schulz, P. E. (2010). Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. European Journal of Neurology, 17(1), 103–110.
doi: 10.1111/j.1468-1331.2009.02801.x
Ye, S., Ji, Y., Li, C., He, J., Liu, X., & Fan, D. (2016). The Edinburgh cognitive and Behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PLoS One, 11(5), e0155496. https://doi.org/10.1371/journal.pone.0155496 .
doi: 10.1371/journal.pone.0155496 pubmed: 27195772 pmcid: 4873026
Zhang, H., Avants, B. B., Yushkevich, P. A., Woo, J. H., Wang, S., McCluskey, L. F., et al. (2007a). High-dimensional spatial normalization of diffusion tensor images improves the detection of white matter differences: An example study using amyotrophic lateral sclerosis. IEEE Transactions on Medical Imaging, 26(11), 1585–1597. https://doi.org/10.1109/TMI.2007.906784 .
doi: 10.1109/TMI.2007.906784 pubmed: 18041273
Zhang, H., Yushkevich, P. A., Rueckert, D., & Gee, J. C. (2007b). Unbiased white matter atlas construction using diffusion tensor images. Med Image Comput Comput Assist Interv, 10(Pt 2), 211–218.
pubmed: 18044571
Zhang, Y., Schuff, N., Woolley, S. C., Chiang, G. C., Boreta, L., Laxamana, J., Katz, J. S., & Weiner, M. W. (2011). Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study. Amyotrophic Lateral Sclerosis, 12(6), 421–429. https://doi.org/10.3109/17482968.2011.593036 .
doi: 10.3109/17482968.2011.593036 pubmed: 21745124 pmcid: 3804304

Auteurs

Sneha Chenji (S)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada. chenji@ualberta.ca.

Abdullah Ishaque (A)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.

Dennell Mah (D)

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.

Esther Fujiwara (E)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Department of Psychiatry, University of Alberta, Edmonton, Canada.

Christian Beaulieu (C)

Department of Biomedical Engineering, University of Alberta, Edmonton, Canada.

Peter Seres (P)

Department of Biomedical Engineering, University of Alberta, Edmonton, Canada.

Simon J Graham (SJ)

Hurvitz Brain Sciences Program, Sunnybrooke Hospital, University of Toronto, Ontario, Canada.

Richard Frayne (R)

Department of Clinical Neuroscience, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Seeman Family MR Centre, Foothills Medical Centre, Calgary, Canada.

Lorne Zinman (L)

Hurvitz Brain Sciences Program, Sunnybrooke Hospital, University of Toronto, Ontario, Canada.

Angela Genge (A)

Montréal Neurological Institute, McGill University, Montréal, Canada.

Lawrence Korngut (L)

Department of Clinical Neuroscience, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.

Wendy Johnston (W)

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.

Sanjay Kalra (S)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH